Expert alert: San Diego scientist available to comment on local dengue case
LJI Professor Sujan Shresta, Ph.D., is a leader in dengue virus research and vaccine development
LJI Professor Sujan Shresta wins new funding to investigate dengue and chikungunya virus vaccines
Shresta and her LJI colleagues work toward pandemic preparedness as members of the national 'ReVAMPP' network
LJI scientists win ‘Prebys Research Heroes’ funding
Prebys Foundation celebrates ground-breaking female researchers
LJI-led team wins top Nucleate honors for virus vaccine development proposal
San Diego scientists work with business experts to advance dengue and Zika virus vaccine strategy
LJI Instructor Annie Elong Ngono, Ph.D., wins GVN support to advance infectious disease research
Elong Ngono, Ph.D., accepted to Global Virus Network Rising Star Mentorship Program
Online exclusive: The dengue problem
Researchers set out to develop a dengue virus vaccine 80 years ago. We still don't have a good one.
How human cells become Zika virus factories
LJI scientists uncover major clue toward developing a pan-flavivirus therapy
Learning from men. Learning from women.
Men and women have different immune systems. With a better understanding of sex-specific immune differences, scientists can more effectively fight infections, cancers, heart disease, and even pregnancy complications.
Q&A with Bjoern Peters, Ph.D.
The bioinformatics tools Dr. Peters has developed are invaluable for immunologists worldwide.
Dengue Virus
The Sette lab’s previous large scale epitope identification efforts (supported by HHS contracts) have led to a deeper understanding of
Shresta Lab
Sujan Shresta,
Ph.D.
Professor
Center for Sex-based Differences in the Immune System, Center for Vaccine Innovation
Sujan Shresta, Ph.D., and her team study the immunology and virology of mosquito-borne human pathogens such as dengue virus and Zika virus.